Meera Varshneya1, Ryan A Devenyi1, Eric A Sobie1. 1. Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY (M.V., R.A.D., E.A.S.).
Abstract
BACKGROUND: The slow and rapid delayed rectifier K+ currents (IKs and IKr, respectively) are responsible for repolarizing the ventricular action potential (AP) and preventing abnormally long APs that may lead to arrhythmias. Although differences in biophysical properties of the 2 currents have been carefully documented, the respective physiological roles of IKr and IKs are less established. In this study, we sought to understand the individual roles of these currents and quantify how effectively each stabilizes the AP and protects cells against arrhythmias across multiple species. METHODS: We compared 10 mathematical models describing ventricular myocytes from human, rabbit, dog, and guinea pig. We examined variability within heterogeneous cell populations, tested the susceptibility of cells to proarrhythmic behavior, and studied how IKs and IKr responded to changes in the AP. RESULTS: We found that (1) models with higher baseline IKs exhibited less cell-to-cell variability in AP duration; (2) models with higher baseline IKs were less susceptible to early afterdepolarizations induced by depolarizing perturbations; (3) as AP duration is lengthened, IKs increases more profoundly than IKr, thereby providing negative feedback that resists excessive AP prolongation; and (4) the increase in IKs that occurs during β-adrenergic stimulation is critical for protecting cardiac myocytes from early afterdepolarizations under these conditions. CONCLUSIONS: Slow delayed rectifier current is uniformly protective across a variety of cell types. These results suggest that IKs enhancement could potentially be an effective antiarrhythmic strategy.
BACKGROUND: The slow and rapid delayed rectifier K+ currents (IKs and IKr, respectively) are responsible for repolarizing the ventricular action potential (AP) and preventing abnormally long APs that may lead to arrhythmias. Although differences in biophysical properties of the 2 currents have been carefully documented, the respective physiological roles of IKr and IKs are less established. In this study, we sought to understand the individual roles of these currents and quantify how effectively each stabilizes the AP and protects cells against arrhythmias across multiple species. METHODS: We compared 10 mathematical models describing ventricular myocytes from human, rabbit, dog, and guinea pig. We examined variability within heterogeneous cell populations, tested the susceptibility of cells to proarrhythmic behavior, and studied how IKs and IKr responded to changes in the AP. RESULTS: We found that (1) models with higher baseline IKs exhibited less cell-to-cell variability in AP duration; (2) models with higher baseline IKs were less susceptible to early afterdepolarizations induced by depolarizing perturbations; (3) as AP duration is lengthened, IKs increases more profoundly than IKr, thereby providing negative feedback that resists excessive AP prolongation; and (4) the increase in IKs that occurs during β-adrenergic stimulation is critical for protecting cardiac myocytes from early afterdepolarizations under these conditions. CONCLUSIONS: Slow delayed rectifier current is uniformly protective across a variety of cell types. These results suggest that IKs enhancement could potentially be an effective antiarrhythmic strategy.
Authors: Jin O-Uchi; J Jeremy Rice; Martin H Ruwald; Xiaorong Xu Parks; Elsa Ronzier; Arthur J Moss; Wojciech Zareba; Coeli M Lopes Journal: J Mol Cell Cardiol Date: 2014-12-02 Impact factor: 5.000
Authors: Jin Li; Claudia Seyler; Felix Wiedmann; Constanze Schmidt; Patrick A Schweizer; Rüdiger Becker; Hugo A Katus; Dierk Thomas Journal: Cardiovasc Res Date: 2013-02-27 Impact factor: 10.787
Authors: Anna Muszkiewicz; Oliver J Britton; Philip Gemmell; Elisa Passini; Carlos Sánchez; Xin Zhou; Annamaria Carusi; T Alexander Quinn; Kevin Burrage; Alfonso Bueno-Orovio; Blanca Rodriguez Journal: Prog Biophys Mol Biol Date: 2015-12-14 Impact factor: 3.667
Authors: Jingqi Q X Gong; Monica E Susilo; Anna Sher; Cynthia J Musante; Eric A Sobie Journal: J Mol Cell Cardiol Date: 2020-04-21 Impact factor: 5.000
Authors: David Adolfo Sampedro-Puente; Jesus Fernandez-Bes; Norbert Szentandrássy; Péter Nánási; Peter Taggart; Esther Pueyo Journal: Front Physiol Date: 2020-01-14 Impact factor: 4.566
Authors: Meera Varshneya; Itziar Irurzun-Arana; Chiara Campana; Rafael Dariolli; Amy Gutierrez; Taylor K Pullinger; Eric A Sobie Journal: medRxiv Date: 2020-05-26
Authors: Meera Varshneya; Itziar Irurzun-Arana; Chiara Campana; Rafael Dariolli; Amy Gutierrez; Taylor K Pullinger; Eric A Sobie Journal: CPT Pharmacometrics Syst Pharmacol Date: 2021-02-11